My Passport
News and Commentary education Live Coronavirus Dashboard
S&P 500 ETF
0.00%
NASDAQ ETF
0.00%
Dow Jones ETF
0.00%


Could SpaceX Overtake Nvidia As The World's B...
Intel-Backed Mobileye's Robotaxi Ambitions Ju...
CoreWeave Is 'Woefully Undervalued', Says Ana...
Netflix Flexes 'M&A Muscle' As Bidding Contes...
AI Data Center Resistance Sweeps The US As $1...
SpaceX To Buy AI Coding Startup Cursor
Moderna Strengthens Commercial Strategy As Pi...
Yum China Buys Pizza Hut Brand In China
The Rise of the Solo General Partner Investor

While modern day venture capital originated in the 1940s, the very first iteration of venture capital (VC) investments--where a general partner (GP) investments capital on behalf of a limited partner (LP)--dates all the way back to the early 1600s with the founding of East India...

  • How are Higher Rates Impacting the Housi...
  • Quantitative Tightening: How the Fed Co...
  • Should Investors Worry About Inflation?
  • How Semiconductors are Made and Why its...
  • What Are NFTs?
    • Inflation: What is it and How to Protect From...
    Short Squeezes Could Lead to Market Dislocati...
    How Google and Facebook Antitrust Lawsuits Co...
    Vaccine News Triggers Growth to Value Rotatio...
    Energy
    Materials
    Industrial
    Finance
    Consumer D...
    Consumer S...
    Informatio...
    Telecommun...
    Health Car...
    Utilities
    Oil
    Gold
    ETFs IPOs Ratings
     
    S&P 500 ETF
    0.00%
    NASDAQ ETF
    0.00%
    Dow Jones ETF
    0.00%
    Search
    News and Commentary
    Education
    Market
    ETFs
    IPOs
    Ratings
    Newsfeed
    My passport
    Login
    Sign up

    STATE STREET SPDR S&P PHARMACEUTICALS ETF (AMEX: XPH)

    Overview
    current price
    $60.22
    $60.22
    change
    0.00 | 0.00%
    0.00 | 0.00%
    Yesterday's Close
    60.22
    open
    0.00
    volume
    0.00 M
    30d. avg volume.
    0.05 M
    1 day
    0.00 - 0.00
    52 weeks
    40.26 - 60.86
    p/e
    0.00
    beta
    0.6032
    market cap
    0.36 B
    dividend yield
    0.62%
    Industry
    -
    XPH by TradingView
    News and Commentary
    Here’s Why Investors Should Consider Biotech, Pharmaceutical Stocks The financial markets are not the most pleasant and calm place right now. It's facing risks in multiple areas such as geopolitics, inflation, and economic growth. There's also th...
    ETF Weekly: Industry Leaders Discuss 2020 Trends at Inside ETFs As exchange-traded fund industry leaders are meeting for the Inside ETFs, the world's largest ETF conference, this week, let's take a look at the latest trends that will be discu...
    ETF Weekly: Funds to Watch Post U.S.-China Trade Deal Stocks have had a volatile start to the week due to investors not knowing the full effect the trade agreement will have on the market and futures. The United States and China sig...
    StockTwits
    StockTwits
    Most Shared
    IBM Is Chasing A '$1 Trillion Value Creation Engine' — And It's Spending $15 Billion To Get There
    Best Buy Stock Pops After Strong Comparable Sales, Margin Growth
    US Says China To Buy At Least $17 Billion Worth Agricultural Goods Annually After Trump-Xi Meet
    Most Popular
    Meta's $125 Billion AI Bet Might Be The Capex Trap Of The Decade
    AI's Memory Shortage Runs Into 2028 — Goldman Stays Bullish On SanDisk, Samsung, SK Hynix
    The AI Spending Boom Just Got Bigger: Goldman Sees $800 Billion Flowing In This Year
    popular tags
    Earnings
    Apple
    Amazon
    Coronavirus
    Tesla
    Coronavirus Impact
    Google
    China
    Covid-19
    mobile iOS
    social Facebook Twitter Youtube Linkedin Rss Google News
    Passport to Wall Street About Us Contact Advertise Privacy Policy Terms of Service
    Sign Up
    © 2026 Passport to Wall Street
    Quotes are at least 20 minutes delayed

    Join now and unlock premium features

    Already Have An Account?